Loading...
Chemical structure of Liarozole dihydrochloride

GC38554

Liarozole dihydrochloride

Also known as 6-[(3-chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole;dihydrochloride

Liarozole dihydrochloride is a P-450 inhibitor and retinoic acid (RA) metabolizing blocking agent inhibits RA metabolism and thereby increases intracellular RA levels in cells that actively produce RA

ChemicalCAS1883548-96-6MW381.69FormulaC17H15Cl3N4
CAS number
1883548-96-6
Molecular weight
381.69
Formula
C17H15Cl3N4
Solubility
Water： ≥ 50 mg/mL (131·00 mM); DMSO： 50 mg/mL (131·00 mM)
InChIKey
NKDMRTVUEJWCCQ-UHFFFAOYSA-N
Catalogue number
GC38554
Brand
GLPBIO
Computed properties PubChem CID 121513844 · TPSA 46.5 Ų · H-bond donors 3 · H-bond acceptors 2
TPSA
46.5 Ų
H-bond donors
3
H-bond acceptors
2
Rotatable bonds
3
Heavy atoms
24

SMILES C1=CC(=CC(=C1)Cl)C(C2=CC3=C(C=C2)N=CN3)N4C=CN=C4.Cl.Cl

Computed descriptors from PubChem (CID 121513844), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.